Cardiomyopathy associated with cancer therapy Journal Article


Authors: Yu, A. F.; Steingart, R. M.; Fuster, V.
Article Title: Cardiomyopathy associated with cancer therapy
Abstract: Chemotherapy-associated cardiomyopathy is a well known cardiotoxicity of contemporary cancer treatment and a cause of increasing concern for both cardiologists and oncologists. As cancer outcomes improve, cardiovascular disease has become a leading cause of morbidity and mortality among cancer survivors. Asymptomatic or symptomatic left ventricular systolic dysfunction in the setting of cardiotoxic chemotherapy is an important entity to recognize. Early diagnosis of cardiac injury through the use of novel blood-based biomarkers or noninvasive imaging modalities may allow for the initiation of cardioprotective medications or modification of chemotherapy regimen to minimize or prevent further damage. Several clinical trials are currently underway to determine the efficacy of cardioprotective medications for the prevention of chemotherapy-associated cardiomyopathy. Implementing a strategy that includes both early detection and prevention of cardiotoxicity will likely have a significant impact on the overall prognosis of cancer survivors. Continued coordination of care between cardiologists and oncologists remains critical to maximizing the oncologic benefit of cancer therapy while minimizing any early or late cardiovascular effects.
Keywords: review; chemotherapy; antineoplastic agent; c reactive protein; exercise; cancer therapy; cancer survivor; cardiotoxicity; echocardiography; congestive heart failure; heart protection; heart muscle; cardiomyopathy; cardiovascular effect; cardiac imaging; troponin; razoxane; cancer prognosis; cardiovascular magnetic resonance; human; natriuretic factor; radioisotope ventriculography
Journal Title: Journal of Cardiac Failure
Volume: 20
Issue: 11
ISSN: 1071-9164
Publisher: Churchill Livingstone  
Date Published: 2014-11-01
Start Page: 841
End Page: 852
Language: English
DOI: 10.1016/j.cardfail.2014.08.004
PROVIDER: scopus
PUBMED: 25151211
PMCID: PMC5972392
DOI/URL:
Notes: Export Date: 1 December 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Richard M Steingart
    175 Steingart
  2. Anthony Yu
    92 Yu